Life Tech MS Sales Decline 5 Percent in Q1 2009, Though Better than Expected

Despite the drop in mass-spec sales, CEO Greg Lucier said "It was a very good quarter for our mass-spec business." Companywide revenues inched up 1 percent to $785M on a pro forma basis.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.